San-San Ou

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

Brian I. Rini, Susan Halabi, Jonathan E. Rosenberg et al. · Journal of Clinical Oncology · 2008 · 908 citations · Full text

Medicine, Oncology, Pharmacology +10

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

Beatriz Grinsztejn, Mina C. Hosseinipour, Heather J. Ribaudo et al. · The Lancet Infectious Diseases · 2014 · 511 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

Adrenal Androgen Levels as Predictors of Outcome in Prostate Cancer Patients Treated with Ketoconazole Plus Antiandrogen Withdrawal: Results from a Cancer and Leukemia Group B Study

Charles J. Ryan, Susan Halabi, San-San Ou et al. · Clinical Cancer Research · 2007 · 91 citations · Full text

Medicine, Oncology, Pharmacology +17

Undisclosed Antiretroviral Drug Use in a Multinational Clinical Trial (HIV Prevention Trials Network 052)

Jessica M. Fogel, Lei Wang, Teresa L. Parsons et al. · The Journal of Infectious Diseases · 2013 · 79 citations · Full text

Public Health, Infectious Disease Control, Hiv Control +12

Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial

Susan H. Eshleman, Sarah E. Hudelson, Andrew D. Redd et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2016 · 76 citations · Full text

Public Health, Infectious Diseases, Preventive Medicine +16